Perceptions towards biologic and biosimilar therapy of patients with rheumatic and gastroenterological conditions

BACKGROUND: Biologic and targeted synthetic disease modifying agents (b/tsDMARDs) have broadened the treatment landscape for autoimmune diseases particularly in patients refractory to conventional DMARDs. More recently, the introduction of biosimilars has reduced the price of bDMARDs, potentially im...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoo, Thomas, Sidhu, Navkiran, Marine, Franca, Lester, Susan, Quinlivan, Alannah, Rowett, Debra, Buchbinder, Rachelle, Hill, Catherine L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783393/
https://www.ncbi.nlm.nih.gov/pubmed/36550585
http://dx.doi.org/10.1186/s41927-022-00309-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783393/
https://www.ncbi.nlm.nih.gov/pubmed/36550585
http://dx.doi.org/10.1186/s41927-022-00309-4

Ejemplares similares